High dose CABG/LVAD+iPSC-CMs for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Mar 2025: Trial registered, NCT06866600

The trials

NCT06866600: IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure

State
Not started
Phase
Phase 1 and Phase 2
People
40 planned
Started
Mar 2025
Primary completion
Dec 2027
Arms
High dose group
Results
None posted
  1. 10 Mar 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.